Puma Biotech gets EU panel nod for breast cancer drug

(Reuters) - Puma Biotechnology Inc  on Friday won a key recommendation from a European Medicines Agency panel on its lead breast cancer drug, five months after the regulator recommended against approving it.

from Reuters: Health News https://ift.tt/2Kym2WS